Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Researchers Identify Drug Candidate for Skin, Hair Regeneration Among Scarred Victims of Burns and Trauma - 08/06/2015

Researchers Identify Drug Candidate for Skin, Hair Regeneration Among Scarred Victims of Burns and Trauma

Experiments with mice and human skin cells have implications for treating people
Release Date: August 6, 2015
dsRNA
Skin cells (keratinocytes) treated with an agent which activates TLR3 (dsRNA) can turn on important regeneration proteins, like Wnt7b (green).

Fast Facts:

  • Study of mice identifies early trigger responsible for spurring regeneration of hair and skin after trauma..
  • Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.

Johns Hopkins researchers have identified a novel cell signaling pathway in mice through which mammals — presumably including people — can regenerate hair follicles and skin while healing from wounds.

The discovery, summarized in an article published Aug. 6 in the journal Cell Stem Cell, could, they say, eventually help spur the growth of new hair, skin or other organ tissue in scarred victims of burns and other injuries.

Our study “uncovers a novel role for a protein that works as a master regulator of regeneration in the skin,” says senior study author Luis A. Garza, M.D., Ph.D., associate professor of dermatology at the Johns Hopkins University School of Medicine. “Medications that turn on this protein have the powerful potential to decrease scarring as healing of wounds takes place, thereby promoting skin and hair follicle regeneration.”

Garza says his team’s work is based on the knowledge that damaged skin releases  double-stranded RNA (dsRNA) — genetic information normally carried by some viruses — that is sensed by a protein called toll-like receptor 3 (TLR3). TLR3, which in other contexts plays a fundamental role in recognizing some disease-causing organisms and activating the immune system, during wounding also activates the genes IL6 and STAT3 to promote hair follicle regeneration.

TLR3 also activates other molecules involved in hair development, including the Wnt and Shh signaling pathways and a gene called EDAR, which makes the protein ectodysplasin and plays an important role in skin development.

Developing embryos have all of the instructions they need to make organs and skin in genetic material within the cells, says Garza. Advanced knowledge about this pathway may lead to therapies that reactivate these early developmental signals to promote healing.

“A lot of human disability is from scarring,” Garza says. “After a heart attack, we’re really good at replacing the blood flow, but it’s the scar on the heart afterward that’s the real problem. We and others in the field of regenerative medicine are interested in how to enhance or trigger regeneration in such situations.”

For the study, Garza and colleagues compared the protein expression of certain genes in healed wounds in two groups of mice. One group was genetically proficient in wound-induced hair neogenesis, a process in mice and rabbits in which skin and hair follicles regenerate after wounds. The other inbred group of mice was noted to lack this ability. Expression of TLR3 was three times higher in the mice that were better able to regenerate hair.

In other experiments, the team found that the expression of TLR3 was five times higher in scratched human skin cell samples compared to healthy skin cell samples, that adding synthetic dsRNA to mouse skin wounds led to a greater number of regenerated follicles, that adding a substance that breaks up dsRNA decreased the number of regenerated follicles, and that regeneration was nearly abolished in mice deficient in TLR3.

Garza notes that it has long been known that skin damage can trigger regeneration. Several cosmetic dermatological procedures, such as chemical peels, dermabrasion and laser treatments, have been used to do that for decades: “One implication from our work is that all of those different rejuvenation techniques are likely working through dsRNA pathways. It may also be that dsRNA could be directly used to stimulate rejuvenation in aging or hair follicle growth in burn patients to regain structures that have been lost.”

The clinical translation of this work is promising because work has already started, says Garza. Drug companies are already developing products to activate TLR3 to trigger the immune system, and these same products could be tested to promote regeneration. But Garza cautions that clinical applications of the team’s discoveries must await many more experiments and the development and testing of drugs that target the pathway they uncovered. He also made clear that the information might not be as applicable to conditions unrelated to scarring or to those whose hair follicles are lost from male pattern baldness.

Study coauthors were Amanda M. Nelson, Ph.D.; Sashank K. Reddy, M.D., Ph.D.; Tabetha S. Ratliff; M. Zulfiquer Hossain, Ph.D.; Adiya S. Katseff; Amadeus S. Zhu; Emily Chang; Sydney R. Resnik; Carly Page, Ph.D.; Dongwon Kim, Ph.D.; Alexander J. Whittam; and Lloyd S. Miller, M.D., Ph.D. The work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases; the Department of Defense’s Armed Forces Institute of Regenerative Medicine; Northrup Grumman Electronic Systems; Alliance for Veterans Support Inc. (Veteran/Amputee Skin Regeneration Program Initiative); and the Thomas Provost, M.D., Young Faculty Development Fund of the Johns Hopkins Department of Dermatology. Johns Hopkins has filed a patent to cover the intellectual property described above. These relationships are being managed by Johns Hopkins in accordance with its conflict of interest policies.

For the Media

Contacts:

Taylor Graham
443-287-8560
tgraha10@jhmi.edu

Marin Hedin
410-502-9429
mhedin2@jhmi.edu